Medinotec (MDNC) Net Income towards Common Stockholders Growth (1y) (2023 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Medinotec | - | - | 854,557.00 | -120.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -120.56% |
| Nov 30, 2025 | 30.00% |
| Aug 31, 2025 | 16.49% |
| May 31, 2025 | 502.75% |
| Feb 28, 2025 | 831.20% |
| Nov 30, 2024 | 163.02% |
| Aug 31, 2024 | 768.46% |
| May 31, 2024 | 375.23% |
| Feb 29, 2024 | 562.52% |
| Nov 30, 2023 | -2,342.02% |
| Aug 31, 2023 | 79.92% |
| May 31, 2023 | 121.87% |
| Feb 28, 2023 | 42.34% |